Search results
Results from the WOW.Com Content Network
Metabolic dysfunction-associated steatohepatitis (MASH) [4] [5] Causes: Genetic, environmental: Risk factors: Obesity, metabolic syndrome, type 2 diabetes mellitus, liver disease: Diagnostic method: Ultrasound, Coexisting metabolic disorders, Liver biopsy: Treatment: Weight loss (in case of obesity) Dietary reduction of fructose and glucose [6 ...
others (excluding postcholecystectomy syndrome), but including other obstructions of the gallbladder (like strictures) hydrops, perforation, fistula; cholesterolosis; biliary dyskinesia; ICD-10 code K83: other diseases of the biliary tract: cholangitis (including ascending cholangitis and primary sclerosing cholangitis)
Steatohepatitis is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver. Mere deposition of fat in the liver is termed steatosis , and together these constitute fatty liver changes.
NAFLD affects about 30% of people in Western countries and 10% of people in Asia. [2] In the United States, rates are around 35% with about 7% having the severe form NASH. [1] NAFLD affects about 10% of children in the United States. [1] Recently the term Metabolic dysfunction-associated fatty liver disease (MAFLD) has been proposed to replace ...
Explanatory model of chronic pain. Chronic pain is defined as reoccurring or persistent pain lasting more than 3 months. [1] The International Association for the Study of Pain (IASP) defines pain as "An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage". [2]
Functional abdominal pain syndrome is a functional gastrointestinal disorder. [4] Functional gastrointestinal disorders (FGD) are common medical conditions characterized by recurrent and persistent gastrointestinal symptoms caused by improper functioning of the enteric system in the absence of any identifiable organic or structural pathology, such as ulcers, inflammation, tumors or masses.
Zieve's syndrome is an acute metabolic condition that can occur during withdrawal from prolonged heavy alcohol use. It is defined by hemolytic anemia (with spur cells and acanthocytes), hyperlipoproteinemia (excessive blood lipoprotein ), jaundice (elevation of unconjugated bilirubin ), and abdominal pain. [ 1 ]
These are also often prescribed for chronic pain due to the impact they have on serotonin and its impact on muscular pain and control. [8] Many providers also use an injectable medication for treatment of AMPS. Opioid use is not recommended for most AMPS cases, as it can worsen recovery, and in rare cases, make the condition worse. [1]